Accueil / Tag Archives: Massachusetts

Tag Archives: Massachusetts

PAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management

Monday, September 18th 2017 at 1:00pm UTC BOSTON–(BUSINESS WIRE)– PAREXEL International Corporation (NASDAQ: PRXL) (« PAREXEL » or the « Company »), a leading global biopharmaceutical services company, announced today that its shareholders, at a special meeting held on September 15, 2017 in Boston, Massachusetts, approved the previously announced proposed acquisition of the Company …

Plus »

Gene Editing Technology Developer Awarded $500,000 Lemelson-MIT Prize

Tuesday, September 19th 2017 at 1:00pm UTC Feng Zhang Recognized for Commitment to Invention, Collaboration and Mentorship CAMBRIDGE, Mass.–(BUSINESS WIRE)– Dr. Feng Zhang, a pioneer of the revolutionary CRISPR gene editing technology, TAL effectors, and optogenics, has just been announced as the recipient of the 2017 $500,000 Lemelson-MIT Prize, the …

Plus »

Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery

Tuesday, September 19th 2017 at 3:00pm UTC Strategic Sponsorship Will Provide Innovative Technology and Nurture Promising Biotechnology Startup SANTA CLARA, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) has announced a platinum sponsorship agreement with LabCentral, a biotech innovation hub based in Cambridge, Massachusetts. LabCentral is an independent, …

Plus »

F-Prime Capital Announces Joshua Grass as New Entrepreneur-in-Residence

Wednesday, September 20th 2017 at 11:30am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– F-Prime Capital, a global venture capital firm focused on investments in healthcare and technology, today announced that Joshua Grass has joined the firm as entrepreneur-in-residence. Mr. Grass will primarily focus on advancing life sciences company-creation activities at F-Prime. “We are excited …

Plus »

Amylyx Pharmaceuticals Receives FDA Orphan Drug Designation for AMX0035 for the Treatment of Amyotrophic Lateral Sclerosis

Tuesday, September 19th 2017 at 1:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMX0035, an oral therapeutic in clinical development for the treatment of amyotrophic lateral sclerosis (ALS). The Company recently began a Phase …

Plus »

First Annual Biotechnical Design Competition Finals in Barcelona

Thursday, September 21st 2017 at 5:09pm UTC Joint European and US teams present designs at the 4th European Congress of Applied Biotechnology, October 1-5, 2017 WOBURN, Mass.–(BUSINESS WIRE)– Tiffany D. Rau, Ph.D., Senior Consultant at BioProcess Technology Consultants (BPTC), is an organizer of the First Annual Biotechnical Design Competition and …

Plus »

AVEO Oncology and EUSA Pharma Announce TiNivo Combination Study Opt-in

Wednesday, September 20th 2017 at 11:10am UTC Exercise of Option Triggers $2.0 Million Research and Development Payment to AVEO CAMBRIDGE, Mass. & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)– AVEO Oncology (NASDAQ:AVEO) and EUSA Pharma today announced that EUSA Pharma, under its multi-territory licensing agreement with AVEO for FOTIVDA® (tivozanib), has opted into …

Plus »

Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

Wednesday, September 20th 2017 at 11:12am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September …

Plus »

Orphan Technologies Applauds Margaret McGlynn for Trailblazer Lifetime Achievement Award

Tuesday, September 19th 2017 at 6:00pm UTC LEXINGTON, Mass.–(BUSINESS WIRE)– Orphan Technologies, a Company dedicated to helping patients control their homocysteine levels, today recognizes Margaret G. McGlynn for receiving the Trailblazer Lifetime Achievement Award. Margaret McGlynn is a member of the Orphan Technologies Board of Directors, President of the HCU …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
Retrouvez nous sur
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...